These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7122105)

  • 21. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants.
    Yen SL; Teng RJ; Ho MM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):379-84. PubMed ID: 8237357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
    Manzar S
    Pediatrics; 2006 May; 117(5):1863; author reply 1863-4. PubMed ID: 16651359
    [No Abstract]   [Full Text] [Related]  

  • 27. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
    Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
    Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus.
    Salzer HR; Salzer-Muhar U; Pollak A; Weninger M
    Lancet; 1987 Apr; 1(8539):977. PubMed ID: 2882363
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of echocardiography to guide the duration of indomethacin treatment of patent ductus arteriosus in preterm infants.
    Bajaj R; Narasimhan R
    J Pediatr; 2010 Aug; 157(2):346; author reply 346. PubMed ID: 20553839
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progresses in treatment of patent ductus arteriosus in premature infants].
    Zhang CC; Cheng GQ
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):871-3. PubMed ID: 23302624
    [No Abstract]   [Full Text] [Related]  

  • 31. Ibuprofen versus indomethacin for closure of patent ductus arteriosus.
    Casalaz D
    N Engl J Med; 2001 Feb; 344(6):457-8. PubMed ID: 11221607
    [No Abstract]   [Full Text] [Related]  

  • 32. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.
    Walters M
    BMJ; 1988 Sep; 297(6651):773-4. PubMed ID: 3142543
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of the patent ductus arteriosus: when, how, and for how long?
    Noori S; Seri I
    J Pediatr; 2009 Dec; 155(6):774-6. PubMed ID: 19914428
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of an aneurysmal dilatation of the ductus arteriosus with indomethacin in a premature infant.
    Doege C; Linderkamp O; Gorenflo M; Bauer J
    Pediatr Cardiol; 2006; 27(1):166-167. PubMed ID: 16261270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
    Yeh TF; Wilks A; Luken J; Pildes RS
    Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
    Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
    Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Presumed side effects of indomethacin in 2 premature infants].
    Pedersen S; Frost L
    Ugeskr Laeger; 1983 Jun; 145(25):1950-1. PubMed ID: 6612815
    [No Abstract]   [Full Text] [Related]  

  • 40. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.